Peregrine Pharmaceuticals (Nasdaq: PPHM) announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) on a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE